SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer
Article in BMC Cancer (January 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in BMC Cancer (January 2024)
Article in Frontiers in Oncology (September 2023)